Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Creese

Showing results (81-90 of 142) with videos related to

Pageof 15
Sort By:
Molecular Pharmacology|July 1, 1976
Binding interactions of lysergic acid diethylamide and related agents with dopamine receptors in the brainD R Burt, I Creese, S H Snyder
Molecular Pharmacology|July 1, 1979
Dopamine receptor binding regulated by guanine nucleotidesI Creese, T B Usdin, S H Snyder
European Journal of Pharmacology|March 1, 1976
Butyrophenone influences on the opiate receptorI Creese, A P Feinberg, S H Snyder
Science (New York, N.Y.)|April 15, 1977
Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brainD R Burt, I Creese, S H Snyder
Science (New York, N.Y.)|August 5, 1977
Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivityI Creese, D R Burt, S H Snyder
European Journal of Pharmacology|July 1, 1979
3H-N-n-propylnorapomorphine: a novel agonist ligand for central dopamine receptorsI Creese, L Padgett, E Fazzini, et al.
Molecular Pharmacology|September 1, 1976
Properties of [3H]haloperidol and [3H]dopamine binding associated with dopamine receptors in calf brain membranesD R Burt, I Creese, S H Snyder
Neuroscience|June 1, 1997
Differential regulation of dopamine receptors after chronic typical and atypical antipsychotic drug treatmentF I Tarazi, W J Florijn, I Creese
Neuroscience Letters|August 31, 1987
The D1 dopamine receptor antagonist SCH 23390 increases cocaine self-administration in the ratG F Koob, H T Le, I Creese
Science (New York, N.Y.)|October 29, 1976
Dopamine receptors and average clinical dosesI Creese, D R Burt, S H Snyder
Pageof 15

Showing results (81-90 of 142) with videos related to

Sort By:
Pageof 15
Molecular Pharmacology|July 1, 1976
Binding interactions of lysergic acid diethylamide and related agents with dopamine receptors in the brainD R Burt, I Creese, S H Snyder
Molecular Pharmacology|July 1, 1979
Dopamine receptor binding regulated by guanine nucleotidesI Creese, T B Usdin, S H Snyder
European Journal of Pharmacology|March 1, 1976
Butyrophenone influences on the opiate receptorI Creese, A P Feinberg, S H Snyder
Science (New York, N.Y.)|April 15, 1977
Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brainD R Burt, I Creese, S H Snyder
Science (New York, N.Y.)|August 5, 1977
Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivityI Creese, D R Burt, S H Snyder
European Journal of Pharmacology|July 1, 1979
3H-N-n-propylnorapomorphine: a novel agonist ligand for central dopamine receptorsI Creese, L Padgett, E Fazzini, et al.
Molecular Pharmacology|September 1, 1976
Properties of [3H]haloperidol and [3H]dopamine binding associated with dopamine receptors in calf brain membranesD R Burt, I Creese, S H Snyder
Neuroscience|June 1, 1997
Differential regulation of dopamine receptors after chronic typical and atypical antipsychotic drug treatmentF I Tarazi, W J Florijn, I Creese
Neuroscience Letters|August 31, 1987
The D1 dopamine receptor antagonist SCH 23390 increases cocaine self-administration in the ratG F Koob, H T Le, I Creese
Science (New York, N.Y.)|October 29, 1976
Dopamine receptors and average clinical dosesI Creese, D R Burt, S H Snyder
Pageof 15